Therefore, early intensive insulin therapy is used as the ideal therapy to restore the β-cell function and to eliminate glucotoxicity in patients with newly diagnosed type 2 diabetes [3, 4]. This evidence concerns the gene INS and type 2 diabetes mellitus.